injectable filler

One treatment procedure primed to propel facial aesthetic procedures forward with unique results and significant science. Irvine, California—February 2, 2012-Syneron Medical Ltd. (NASDAQ: ELOS), www.syneron.com , the global leader in medical aesthetic products and technology, announces the launch of evolastin(TM) – the industry’s first energy-based dermalremodeling procedure that delivers controlled radio frequency energy directly to the deepdermis to stimulate the skin’s natural production of collagen, elastin and hyaluronic acidin a single treatment

Event Date:  February 18, 19, 2012 Event Location: Toronto, Canada Presented by the International Association for Physicians in Aesthetic Medicine ( IAPAM ) presents the Botox Dermal Filler Bootcamp will give you two days of the most intensive hands-on cosmetic injectable training available in North America. This intensive 2 day Botox and Dermal Filler training program will cover injecting all 10 areas of the upper and lower face.

Presented by the IAPAM , the Aesthetic Practice Startup Workshop will prepare you for all the steps needed to add aesthetic medicine to your practice. This session is lead by medical spa industry expert, Jeff Russell, and will certainly help you avoid some of the common pitfalls of the medical spa / aesthetic medicine industry.  If you are going to open a medical spa or incorporate medical aesthetics into your existing practice, you can’t afford to miss this workshop

Excerpt Forget the facelift.

Patients who don’t like the vertical lines that form above the lips when they pucker up may benefit from botulinum toxin injections.

Aside from plastic surgery, Botox has been the best anti-aging weapon up until now.

Merz Pharmaceuticals, LLC, today announced that data from studies evaluating the dosing and adverse event profiles of Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, in the treatment of blepharospasm (eyelid spasms) will be presented at the 115th Annual Meeting of the American Association of Ophthalmology (AAO) in Orlando, Fla. These data include an extension of the Phase III, randomized, placebo-controlled, double-blind trial that assessed the safety and efficacy of XEOMIN in blepharospasm, which was recently published in the July 2011 issue of Movement Disorders , the official journal of the Movement Disorders Society.

Some reports indicate that “40 to 45% of American adults make one or more resolutions each year,” and “among the top New Year’s resolutions are personal goals about weight loss.” It has also been found that 64% of “New Year’s Resolutions are kept after 1 month, but only 46% maintained their resolutions past 6 months.”  By attending the IAPAM’s hCG for Weight Loss Training, physicians can help their patients reach their weight loss goals, while creating a profitable hCG diet program within their practice.   “Losing weight”, “going on a diet,” and “getting healthier” are perennially in the top 3 of New Year’s Resolutions.  The IAPAM’s Physician hCG Training ( http://www.hcgtraining.com ) offers physicians a full-day of intensive education on the clinical best practices of hCG  (human Chorionic Gonadotropin) for weight loss, lipotropic injections and Very Low Calorie Diet (VLCD) programs.

A new report shows that the market for botox ® is growing at a rate of 9% annually, and dentists are poised to capture a significant portion of this market by attending accredited hands-on, physician-taught botox ® training like that offered by the IAPAM at its respected Aesthetic Medicine Symposium.   The market for botox ® treatments is growing.

The IAPAM recently identified a correlation between the increase in physicians engaging in the IAPAM’s comprehensive, hands-on Botox ® Training, and the significant growth in botox ® and dermal filler procedures .